Filters
Sort results
Reset
Apply
Cat No. | Products Name | Name | Previous Name | Target | Format | Options | Order | quote |
|---|---|---|---|---|---|---|---|---|
Pre-Made Lonigutamab biosimilar, Whole mAb, Anti-IGF1R Antibody: Anti-IGFR/CD221/IGFIR/JTK13 therapeutic antibody |
Lonigutamab |
NA |
IGF1R |
Whole mAb |
||||
Pre-Made Lorukafusp biosimilar, Whole mAb Fusion: Anti-Ganglioside GD2 therapeutic antibody |
Lorukafusp |
NA |
Ganglioside GD2 |
Whole mAb Fusion |
||||
Pre-Made Lorvotuzumab biosimilar, Whole mAb ADC, Anti-NCAM1 Antibody: Anti-CD56/NCAM/MSK39 therapeutic antibody |
Lorvotuzumab |
NA |
NCAM1 |
Whole mAb ADC |
||||
Pre-Made Losatuxizumab biosimilar, Whole mAb ADC, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Losatuxizumab |
NA |
EGFR |
Whole mAb ADC |
||||
Pre-Made Lucatumumab biosimilar, Whole mAb, Anti-CD40 Antibody: Anti-p50/Bp50/CDW40/TNFRSF5 therapeutic antibody |
Lucatumumab |
NA |
CD40 |
Whole mAb |
||||
Pre-Made Lulizumab biosimilar, Single Domain Variable Fragment;L, Anti-CD28 Antibody: Anti-Tp44 therapeutic antibody |
Lulizumab |
NA |
CD28 |
Single Domain Variable Fragment;L |
||||
Pre-Made Lumiliximab biosimilar, Whole mAb, Anti-FCER2/CD23 Antibody: Anti-BLAST-2A/CLEC4J/FCE2/FCErII/IGEBF therapeutic antibody |
Lumiliximab |
NA |
FCER2 |
Whole mAb |
||||
Pre-Made Lumretuzumab biosimilar, Whole mAb, Anti-ERBB3/Erbb-3 Antibody: Anti-ErbB-3/FERLK/HER3/LCCS2/MDA-BF-1/VSCN1/c-erbB-3/c-erbB3/erbB3-S/p180-ErbB3/p45-sErbB3/p85-sErbB3 therapeutic antibody |
Lumretuzumab |
NA |
ERBB3 |
Whole mAb |
||||
Pre-Made Lupartumab biosimilar, Whole mAb ADC, Anti-LYPD3 Antibody: Anti-C4.4A therapeutic antibody |
Lupartumab |
NA |
LYPD3 |
Whole mAb ADC |
||||
Pre-Made Lusvertikimab biosimilar, Whole mAb, Anti-IL7R Antibody: Anti-CD127/CDW127 therapeutic antibody |
Lusvertikimab |
NA |
IL7R |
Whole mAb |
||||
Pre-Made Lutikizumab biosimilar, Bispecific Dual Variable Domain IG, Anti-IL1A;IL1B Antibody: Anti-IL1/IL-1A/IL1F1/IL1-ALPHA/IL-1 alpha;IL-1/IL1-BETA/IL1F2/IL1beta therapeutic antibody |
Lutikizumab |
NA |
IL1A,IL1B |
Bispecific Dual Variable Domain IG |
||||
Pre-Made Maftivimab biosimilar, Whole Mab: Anti-Zaire Ebolavirus GP therapeutic antibody |
Maftivimab |
NA |
Zaire Ebolavirus GP |
Whole mAb |
||||
Pre-Made Magrolimab biosimilar, Whole mAb, Anti-CD47 Antibody: Anti-IAP/OA3/MER6 therapeutic antibody |
Magrolimab |
NA |
CD47 |
Whole mAb |
||||
Pre-Made Manelimab biosimilar, Whole mAb, Anti-CD274/PD-L1 Antibody: Anti-B7-H/B7H1/PDCD1L1/PDCD1LG1 therapeutic antibody |
Manelimab |
NA |
PDL1 |
Whole mAb |
||||
Pre-Made Margetuximab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody |
Margetuximab |
NA |
ERBB2 |
Whole mAb |
||||
Pre-Made Marstacimab biosimilar, Whole mAb, Anti-ERBB2/HER2 Antibody: Anti-CD340/neu/MLN 19/NEU/NGL/TKR1/VSCN2 therapeutic antibody |
Marstacimab |
NA |
ERBB2 |
Whole mAb |
||||
Pre-Made Matuzumab biosimilar, Whole mAb, Anti-EGFR Antibody: Anti-ERBB/ERRP/HER1/mENA/ERBB1/PIG61/NISBD2 therapeutic antibody |
Matuzumab |
NA |
EGFR |
Whole mAb |
||||
Pre-Made Mavezelimab biosimilar, Whole mAb, Anti-LAG3 Antibody: Anti-CD223 therapeutic antibody |
Mavezelimab |
favezelimab |
LAG3 |
Whole mAb |
||||
Pre-Made Mavrilimumab biosimilar, Whole mAb, Anti-CSF2RA Antibody: Anti-GMR/CD116/CSF2R/SMDP4/CDw116GMR-alpha/GMCSFR-alpha/GM-CSF-R-alpha therapeutic antibody |
Mavrilimumab |
favezelimab |
CSF2RA |
Whole mAb |
||||
Pre-Made Melrilimab biosimilar, Whole mAb, Anti-IL1RL1/ST2 Antibody: Anti-DER4/FIT-1/IL33R/T1 therapeutic antibody |
Melrilimab |
NA |
IL1RL1 |
Whole mAb |
